Skip to main content
Full access
New Research
Published Online: 1 May 2011

Association of Cerebrovascular Events With Antidepressant Use: A Case-Crossover Study

Abstract

Objective:

The authors sought to assess the risk of cerebrovascular events associated with use of antidepressant medications.

Method:

The authors conducted a case-crossover study of 24,214 patients with stroke enrolled in the National Health Insurance Research Database in Taiwan from 1998 to 2007. The authors compared the rates of antidepressant use during case and control time windows of 7, 14, and 28 days. Adjustments were made for time-dependent variables, such as health system utilization and proposed confounding medications. Stratified analyses were performed for valuing the interaction between the stroke risk of antidepressant use and age, sex, presence of mood disorder, stroke type, severity of chronic illness, and duration of antidepressant treatment. A conditional logistic regression model was used to determine the odds of antidepressant use during case time windows.

Results:

The adjusted odds ratio of stroke risk with antidepressant exposure was 1.48 (95% confidence interval=1.37–1.59) using 14-day time windows. Stroke risk was negatively associated with the number of antidepressant prescriptions reported. Use of antidepressants with high inhibition of the serotonin transporter was associated with a greater risk of stroke than use of other types of antidepressants.

Conclusions:

These findings suggest that antidepressant use may be associated with an increased risk of stroke. However, the underlying mechanisms remain unclear.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 511 - 521
PubMed: 21406464

History

Received: 28 July 2010
Revision received: 19 November 2010
Accepted: 23 November 2010
Published online: 1 May 2011
Published in print: May 2011

Authors

Details

Chi-Shin Wu, M.D., M.Sc.
From the Department of Psychiatry, Far Eastern Memorial Hospital, Taipei, Taiwan; Department of Psychiatry, National Taiwan University Hospital, Taipei; Division of Mental Health and Substance Abuse Research, Institute of Population Health Sciences, National Health Research Institutes, Taipei; Department of Psychiatry, National Taiwan University College of Medicine; and Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taipei.
Sheng-Chang Wang, M.D., M.Sc.
From the Department of Psychiatry, Far Eastern Memorial Hospital, Taipei, Taiwan; Department of Psychiatry, National Taiwan University Hospital, Taipei; Division of Mental Health and Substance Abuse Research, Institute of Population Health Sciences, National Health Research Institutes, Taipei; Department of Psychiatry, National Taiwan University College of Medicine; and Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taipei.
Yu-Cheng Cheng, M.Sc.
From the Department of Psychiatry, Far Eastern Memorial Hospital, Taipei, Taiwan; Department of Psychiatry, National Taiwan University Hospital, Taipei; Division of Mental Health and Substance Abuse Research, Institute of Population Health Sciences, National Health Research Institutes, Taipei; Department of Psychiatry, National Taiwan University College of Medicine; and Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taipei.
Susan Shur-Fen Gau, M.D., Ph.D.
From the Department of Psychiatry, Far Eastern Memorial Hospital, Taipei, Taiwan; Department of Psychiatry, National Taiwan University Hospital, Taipei; Division of Mental Health and Substance Abuse Research, Institute of Population Health Sciences, National Health Research Institutes, Taipei; Department of Psychiatry, National Taiwan University College of Medicine; and Graduate Institute of Epidemiology, National Taiwan University College of Public Health, Taipei.

Notes

Address correspondence and reprint requests to Dr. Gau, Department of Psychiatry, National Taiwan University Hospital and College of Medicine, No. 7, Chung-Shan South Rd., Taipei 10002, Taiwan; [email protected] (e-mail).

Funding Information

Dr. Wu has received speaking honoraria from Eli Lilly and travel funds from Astellas. Dr. Gau has received speaking honoraria and travel funds from Eli Lilly, has been an investigator in two clinical trials from Eli Lilly, and has received speaking honoraria from Janssen and AstraZeneca. The other authors report no financial relationships with commercial interests.Supported by grant FEMH-99-C-041 from Far Eastern Memorial Hospital; manuscript preparation was supported by grant NSC96-2628-B-002-069-MY3 from the National Science Council, Taiwan.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share